Albright's hereditary osteodystrophy and pseudohypoparathyroidism

Area of Science:

• Endocrinology
• Genetics
• Molecular Biology

Background:

• Albright's hereditary osteodystrophy (AHO) is a syndrome with characteristic physical features.
• Pseudohypoparathyroidism (PHP) is defined by end-organ resistance to parathyroid hormone (PTH).
• AHO and PHP are not interchangeable, with Pseudopseudohypoparathyroidism (PPHP) describing AHO without PTH resistance.

Purpose of the Study:

• To clarify the relationship between Albright's hereditary osteodystrophy (AHO) and Pseudohypoparathyroidism (PHP).
• To explain the genetic and epigenetic basis of different PHP subtypes and PPHP.

Main Methods:

• Review of clinical and genetic findings in patients with AHO, PHP, and PPHP.
• Analysis of GNAS1 gene mutations and their association with imprinting patterns.
• Classification of PHP subtypes based on clinical presentation and molecular etiology.

Main Results:

• Heterozygous deactivating GNAS1 mutations cause AHO and are linked to PHP type Ia (PHPIa) and PPHP.
• Maternal GNAS1 mutations typically result in PHPIa, while paternal mutations usually lead to PPHP due to genomic imprinting.
• Pseudohypoparathyroidism type Ib (PHPIb) can arise from GNAS1 mutations or imprinting defects in the upstream exon 1A.
• Etiologies for PHP type Ic and type II remain largely unclear.

Conclusions:

• GNAS1 gene mutations and imprinting are central to the pathogenesis of PHPIa and PPHP.
• Tissue-specific imprinting of GNAS1 explains the differential clinical manifestations (PHP vs. PPHP) based on parental origin of the mutation.
• Further research is needed to elucidate the causes of PHP type Ic and type II.